Inventor · disambiguated record
Virginia Ammendola
Also filed as: AMMENDOLA VIRGINIA
13 granted patents·8 pending applications·38 citations·filing 2010–2024
88Inventor score
Files withGLAXOSMITHKLINE BIOLOGICALS SA16US GOV HEALTH & HUMAN SERVICES2COLLOCA STEFANO1SULLIVAN NANCY J1THE GOVERNMENT OF THE US SECRETARY OF THE DEPARTMENT OF1
Top patents by PatentIndex Score
21 records- 0190US9718863B2Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereofCOLLOCA STEFANO·Filed 2010·Granted Aug 1, 2017·19 cites·14 claims
- 0289US10544192B2Chimpanzee clade E adenovirus nucleic acid-and amino acid-sequences, vectors containing same, and uses thereofGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Granted Jan 28, 2020·8 cites·3 claims
- 0388US9526777B2Methods for the induction of ebola virus-specific immune responses comprising administering a replication-defective chimpanzee adenovirus vector expressing the ebola virus glycoproteinSULLIVAN NANCY J·Filed 2011·Granted Dec 27, 2016·7 cites·5 claims
- 0483US11254710B2Adenovirus polynucleotides and polypeptidesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Granted Feb 22, 2022·2 cites·12 claims
- 0581US11414679B2Adenovirus polynucleotides and polypeptidesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Granted Aug 16, 2022·2 cites·22 claims
- 0676US11913013B2Chimpanzee adenoviral vector-based filovirus vaccinesUS GOV HEALTH & HUMAN SERVICES·Filed 2021·Granted Feb 27, 2024·0 cites·5 claims
- 0774US11214599B2Recombinant simian adenoviral vectors encoding a heterologous fiber protein and uses thereofGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2019·Granted Jan 4, 2022·0 cites·17 claims
- 0874US2022220157A1Adenovirus polynucleotides and polypeptidesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Application pending·0 cites
- 0973US2022204566A1Adenovirus polynucleotides and polypeptidesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2021·Application pending·0 cites
- 1071US11795478B2Adenovirus polynucleotides and polypeptidesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Granted Oct 24, 2023·0 cites·24 claims
- 1171US2023158134A1Chimpanzee adenovirus constructs with lyssavirus antigensGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Application pending·0 cites
- 1270US2024382583A1Hepatitis b immunisation regimen and compositionsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2024·Application pending·0 cites
- 1367US2020149069A1Chimpanzee adenoviral vector-based filovirus vaccinesTHE GOVERNMENT OF THE US SECRETARY OF THE DEPARTMENT OF·Filed 2020·Application pending·0 cites
- 1465US2021060150A1Novel adenovirusGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2020·Application pending·0 cites
- 1564US10584355B2Chimpanzee adenoviral vector-based filovirus vaccinesUS GOV HEALTH & HUMAN SERVICES·Filed 2016·Granted Mar 10, 2020·0 cites·16 claims
- 1663US11957749B2Hepatitis B immunization regimen and compositionsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2018·Granted Apr 16, 2024·0 cites·9 claims
- 1761US11254711B2Adenovirus polynucleotides and polypeptidesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Granted Feb 22, 2022·0 cites·16 claims
- 1857US11702674B2Simian adenovirus vectors comprising the ChAd-157 fiber proteinGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2019·Granted Jul 18, 2023·0 cites·24 claims
- 1953US2022112245A2Chimpanzee adenovirus constructs with lyssavirus antigensGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Application pending·0 cites
- 2051US11268108B2Replication competent adenoviral vectorsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2018·Granted Mar 8, 2022·0 cites·18 claims
- 2143US2021069322A1Hepatitis b immunisation regimen and compositionsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Virginia Ammendola files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →